-
公开(公告)号:US11285151B2
公开(公告)日:2022-03-29
申请号:US16549226
申请日:2019-08-23
申请人: Emory University
IPC分类号: A61K31/506 , A61K45/06 , A61K31/4166 , A61K31/57 , A61K31/575 , A61K31/58 , A61K31/505 , A61K31/137 , A61K31/138 , A61K31/167 , A61K31/444 , A61K38/20 , C07D403/12 , C07D213/74 , C07D401/12 , C07D239/42 , C07D213/72 , C07C211/53 , C07C233/64 , C07C255/58 , C07C211/52 , C07C229/60 , C07C279/04 , C07C279/18 , C07C211/27 , C07C233/11 , C07C233/58 , C07C233/65 , C07C233/75 , C07C237/40
摘要: The disclosure provides methods of use of certain compounds that are useful for treating certain symptoms of endocrine disturbances, and in particular those associated with hot flashes.
-
公开(公告)号:US11261378B2
公开(公告)日:2022-03-01
申请号:US15539666
申请日:2015-12-17
申请人: DIC CORPORATION
发明人: Masahiro Horiguchi , Sayaka Nose , Akihiro Koiso
IPC分类号: C09K19/54 , C07C69/753 , C07C69/76 , C07D333/22 , C07D339/06 , C07D339/08 , C07D407/12 , C07D409/12 , C07C323/21 , C07D413/12 , C07D417/04 , C07D417/06 , C07D249/06 , C07C327/48 , C07C251/24 , C07D207/452 , C07C251/86 , C07C251/88 , C07D209/12 , C07D277/82 , C07D513/04 , C08F20/10 , G02B5/30 , C07C69/94 , C07C69/75 , C09K19/34 , C07D409/14 , C07D305/06 , C07C251/78 , C07D403/04 , C07D209/40 , C07D303/48 , C09K19/32 , C07D495/04 , C07C69/757 , C07C245/08 , C07D333/36 , C07D307/66 , C07D403/12 , C07D417/12 , C07D265/16 , C07D249/04 , C07D213/74 , C07C251/18 , C07D409/06 , C07D333/76 , C07D277/64 , C07D209/88 , C09K19/38 , G02F1/13363 , C09K19/04 , C08F220/30
摘要: The present invention aims to provide a polymerizable compound that has high storage stability without causing crystal precipitation when added to a polymerizable composition and to provide a polymerizable composition containing the polymerizable compound. A polymer film produced by polymerization of the polymerizable composition has a low haze, high thickness uniformity, low occurrence of nonuniform orientation, high surface hardness, high adhesiveness, and good appearances and fewer orientation defects even after ultraviolet irradiation. The present invention also aims to provide a polymer produced by polymerization of the polymerizable composition and an optically anisotropic body produced from the polymer.
-
公开(公告)号:US20220056540A1
公开(公告)日:2022-02-24
申请号:US17522332
申请日:2021-11-09
发明人: Jeroen DE ROOS , Joost Cornelis Marinus UITDEHAAG , Adrianus Petrus Antonius DE MAN , Rogier Christiaan BUIJSMAN , Guido Jenny Rudolf ZAMAN
IPC分类号: C12Q1/6886 , C07D213/74 , C07D239/48 , C07D471/04 , C07D471/14 , C07D473/16 , C07D487/04
摘要: A method for identifying a tumor that is susceptible to treatment with a TTK inhibitor, including: a) providing a sample of a tumor; b) determining the presence of a mutated CTNNB1 gene in the sample, wherein the mutation is located in exon 3 of CTNNB1 and the presence of a mutated CTNNB1 gene indicates the tumor is susceptible to treatment with a TTK inhibitor. Alternatively, step b) is replaced by the step of determining the presence of a mutated CTNNB1 protein in the sample, wherein the mutation is located in exon 3 of CTNNB1 and the presence of a mutated CTNNB1 protein indicates the tumor is susceptible to treatment with a TTK inhibitor. In a further alternative, step b) includes determining an altered expression of a CTNNB1 regulated gene, whereby an altered expression of a CTNNB1 regulated gene indicates the tumor is susceptible to treatment with a TTK inhibitor.
-
公开(公告)号:US20220054364A1
公开(公告)日:2022-02-24
申请号:US17464211
申请日:2021-09-01
申请人: MESOSIL INC.
IPC分类号: A61K6/84 , A61L27/56 , C07C279/26 , C07D213/74 , C07C279/14 , A61K31/4425 , A61K31/155 , C07D213/20 , A61K31/444 , A61L27/54 , A61K9/00 , A61L27/42 , A61L27/30 , A61L27/44 , A61K9/14 , A61P1/02 , A01N25/08 , A61P31/04 , A61P31/02 , A61K9/51 , A61L27/32 , A61K31/785 , A61L27/12 , A61L27/10 , A61L27/02 , A01N43/40 , A01N47/44 , A61K31/20 , A61K6/20 , A61K6/35 , A61K6/40 , A61K6/54 , A61K6/71 , A61K6/74 , A61K6/76 , A61K6/80 , A61K6/86 , A61K6/802 , A61K6/849 , A61K6/853 , A61K6/864 , A61K6/871 , C08K3/22 , C08K3/32 , C08L33/12
摘要: A biocompatible composite material for controlled release is disclosed, comprising a biocompatible metal oxide structure with a loaded network of pores. The pore network of the biocompatible composite material is filled with a uniformly distributed biologically active micellizing amphiphilic molecule, the size of these pores ranging from about 0.5 to about 100 nanometers. The material is characterized in that when exposed to phosphate-buffered saline (PBS), the controlled release of the active amphiphilic molecule is predominantly diffusion-driven over time.
-
35.
公开(公告)号:US20220033407A1
公开(公告)日:2022-02-03
申请号:US17414672
申请日:2019-12-13
申请人: NOVARTIS AG
发明人: Mihai D. Azimioara , Bei Chen , Robert Epple , Declan Hardy , Ayako Honda , Philip Lam , Hasnain Ahmed Malik , Fabio Meier , Truc Ngoc Nguyen , Barun Okram , Sejal Patel , Rodrigo Rodriguez , Duncan Shaw , Yiping Shen , Baogen WU
IPC分类号: C07D487/10 , C07D401/04 , C07D213/74 , C07D413/04 , C07D491/107 , A61K45/06
摘要: The invention relates to heterocyclic compounds of the formula (I), in which all of the variables are as defined in the specification; capable of modulating the activity of CFTR. The invention further provides a method for manufacturing compounds of the invention, and its therapeutic uses. The invention further provides methods to their preparation, to their medical use, in particular to their use in the treatment and management of diseases or disorders including Cystic fibrosis and related disorders.
-
公开(公告)号:US11236109B2
公开(公告)日:2022-02-01
申请号:US16357148
申请日:2019-03-18
发明人: Zhe Li , Qing Xu , Brian W. Metcalf , Stephen L. Gwaltney, II , Jason R. Harris , Calvin W. Yee
IPC分类号: C07D401/04 , C07D498/08 , C07D491/107 , C07D213/74 , C07D403/04
摘要: Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
-
公开(公告)号:US20220006018A1
公开(公告)日:2022-01-06
申请号:US17293515
申请日:2019-11-12
申请人: Merck Patent GmbH
发明人: Philipp STOESSEL
IPC分类号: H01L51/00 , C07D213/16 , C07F15/00 , C07D209/94 , C07D215/06 , C07D405/14 , C07D213/74 , C07D213/06 , C07D403/04 , C07C211/54 , C07D251/24
摘要: The invention relates to compounds that can be used for producing functional layers of electronic devices, in particular for use in electronic devices. The invention further relates to a process for preparing the compounds according to the invention, and to electronic devices comprising same.
-
公开(公告)号:US11104653B2
公开(公告)日:2021-08-31
申请号:US16404255
申请日:2019-05-06
发明人: Garret Miyake , Chern-Hooi Lim , Max Kudisch , Bin Liu
IPC分类号: C07D295/073 , C07D211/62 , C07D211/46 , C07C209/68 , C07D307/52 , C07D213/74 , C07D213/38 , C07D239/26 , C07D235/26 , B01J19/12 , B01J27/08 , B01J35/00 , C07D211/06
摘要: The disclosure relates to a method for forming aryl carbon-nitrogen bonds and to photoreactors useful in these and other light-driven reactions. The method comprises contacting an aryl halide, such as 4-bromobenzotrifluoride, with an amine, such as morpholine, in the presence of a Ni salt catalyst solution and an optional base, thereby forming a reaction mixture; exposing the reaction mixture to light under reaction condition sufficient to produce the aryl carbon-nitrogen bonds, e.g., to give a product such as 4-(4-(trifluoromethyl)phenyl)morpholine. In certain embodiments, the amine may be present in a molar excess to the aryl halide. In certain embodiments, the Ni salt catalyst solution includes a Ni(II) salt and a polar solvent, wherein the Ni(II) salt is dissolved in the polar solvent. In certain embodiments, the reactions conditions include holding the reaction mixture at between about room temperature and about 80° C. for between about 1 hour and about 20 hours such that at least about 50% yield is obtained.
-
公开(公告)号:US11072608B2
公开(公告)日:2021-07-27
申请号:US16443596
申请日:2019-06-17
发明人: Ottmar Franz Hueter , Andrew Edmunds , Andre Jeanguenat , Pierre Joseph Marcel Jung , Anke Buchholz , Michel Muehlebach
IPC分类号: C07D213/74 , C07D213/72 , C07D213/70 , C07D213/71 , C07D471/04 , A01N43/90
摘要: Compounds of formula I(I), wherein the substituents are as defined in claim 1, and the agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of those compounds, can be used as insecticides and can be prepared in a manner known per se.
-
公开(公告)号:US20210188763A1
公开(公告)日:2021-06-24
申请号:US16767919
申请日:2018-11-29
发明人: John P. Chute , Michael E. Jung , Emelyne Diers , Hyo Jin Gim , Martina Roos
IPC分类号: C07C225/20 , C07F7/12 , C07C311/39 , C07D307/52 , C07D317/66 , C07D231/12 , C07C205/43 , C07D207/333 , C07D333/22 , C07D249/06 , C07C233/88 , C07C233/15 , C07C225/22 , C07D211/58 , C07C233/66 , C07C255/58 , C07D231/56 , C07D213/74 , C07D401/06 , C07D333/36 , C07D213/50 , A61P7/06
摘要: The invention relates to compounds that promote hematopoietic regeneration. The invention further relates to methods of promoting hematopoietic regeneration using the novel compounds of the invention.
-
-
-
-
-
-
-
-
-